This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Series

Charles Mackay, PhD, FAA
Professor at Monash University


Charles Mackay did his Ph.D at Melbourne University, and worked at the Basel Institute for Immunology, LeukoSite Inc. and Millennium Therapeutics in Boston USA, and Garvan Institute in Sydney, before moving to Monash University in mid 2009.

Charles Mackay is accomplished in the fields of inflammation, GPCR biology, cell migration and cytokine biology. Charles Mackay is a leading advocate of a new explanation for many ‘western lifestyle' diseases - that diet, gut microbes and their metabolites are responsible. He is commercializing a new ‘medicinal foods’ approach for the treatment of many human diseases. He is a leader in the field of metabolite-sensing GPCRs. His other interests include inflammatory diseases such as asthma, arthritis, type 1 diabetes, colitis, and Western lifestyle disease such as food allergy, fatty liver disease, hypertension and Alzheimer’s disease.